已收盤 10-10 16:00:00 美东时间
-0.920
-3.65%
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从15美元升至18美元;Ascendiant Capital:维持Surgepays"买入"评级,目标价从9美元升至9.5美元
10-06 08:35
Khrom Capital Management LLC ("Khrom Capital"), which together with its investment funds and affiliates, owns 5.5% of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") and is one of the Company's
10-02 05:03
Acadia Healthcare shares are trading higher after the Financial Times reported ...
09-24 19:34
今日重点评级关注:瑞银:上调Gossamer Bio评级至"买入",目标价从1.25美元升至9美元;Canaccord Genuity:维持Corcept Therapeutics"买入"评级,目标价从137美元升至140美元
09-11 10:06
The stock is up following a Friday announcement that the cloud computing company will be added to the S&P MidCap 400.
09-09 04:10
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250905-1479730/1479730_sept2025-1500rebalance.pdf
09-06 05:51
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-15 01:45
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
Barclays analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Equal-Weight and lowers the price target from $28 to $20.
08-07 21:02